Sotera Health subsidiary Sterigenics settles 129 EO claims for $34M

Sotera Health Co

• Sterigenics enters binding term sheet to resolve 129 ethylene oxide (EO) claims for $34,000,000.
• Settlement includes 10 claims set for trial in Oct 2025 and Mar 2026; process expected 60–90 days.
• Settlement conditioned on 100% claimant participation, stays of trials, and court good-faith determination; Sterigenics can waive participation requirement.
• Sterigenics denies any liability; term sheet explicitly states no admission of hazard from Willowbrook facility.
• The settlement dismisses claims with prejudice and covers 56 pending lawsuits and 63 unfiled claims.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.